Eli Lilly and Company: Clinical Trials & Research Profile
Biopharma Industry (Indianapolis, IN) · Primary Focus: Endocrinology, Obesity, and Metabolic
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Indianapolis, IN) |
| Primary Therapeutic Area | Endocrinology, Obesity, and Metabolic |
| Active Phase II & III Studies | 146 active (77 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 334 (262 with California sites) |
| Completed vs Early-Stopped Studies | 156 completed / 32 stopped (9.6% stop rate) |
| Median Closed Enrollment | 312 participants |
| FDA Drugs@FDA Original Approvals | 88 all-time (16 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 100.0% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Eli Lilly and Company across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk